Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):132–140. doi: 10.1097/QAI.0b013e318224d2e9

Table 1.

Epitope-specific CD8 T-cell lines used in the in vitro suppression assay.

Patient
ID
Line# HLA Restriction-
Epitopea
Proteinb AA Sequence
P4470 P1 B07-HA9 Gag p24 (84–92) HPVHAGPIA
P2 B07-RL9 Nef (77–85) RPMTYKAAL

P5766 P3 A02-FK10 p2p7p1p6 (70–79) FLGKIWPSYK
P4 B51-TI8 RT (128–135) TAFTIPSI
P5 B35-TY9 RT (107–115) TVLDVGDAY

P1918 P6 A03-RK9 Gag p17 (20–28) RLRPGGKKK

P2824 P7 B57-IW9 Gag p24 (15–23) ISPRTLNAW
P8 B57-KF11 Gag p24 (30–40) KAFSPEVIPMF

P2883 P9 B53-EW10 Gag p24 (71–80) ETINEEAAEW

C6602 C1 B58-TF11 Gag p24 (108–118) TSTLQEQIGWF

C5168 C2 B27-KK10 Gag p24 (131–140) KRWIILGLNK

C2795 C3 B57-KF11 Gag p24 (30–40) KAFSPEVIPMF
C4 B57-QW9 Gag p24 (176–184) QASQEVKNW

C1655 C5 B57-KF11 Gag p24 (30–40) KAFSPEVIPMF
C6 B57-TF11 Gag p24 (108–118) TSTLQEQIGWF
a

Underlined epitopes represent those restricted by HLA class I alleles associated with delayed disease progression.

b

Numbers in parentheses indicate epitope alignment to the HIV-1HXB2 reference strain.